1. Academic Validation
  2. A new human MR splice variant is a ligand-independent transactivator modulating corticosteroid action

A new human MR splice variant is a ligand-independent transactivator modulating corticosteroid action

  • Mol Endocrinol. 2001 Sep;15(9):1586-98. doi: 10.1210/mend.15.9.0689.
M C Zennaro 1 A Souque S Viengchareun E Poisson M Lombès
Affiliations

Affiliation

  • 1 INSERM U 478, Faculté de Médecine Xavier Bichat, 75870 Paris Cedex 18, France. zennaro@infobiogen.fr
Abstract

Aldosterone effects are mediated by the MR, which possesses the same affinity for mineralocorticoids and glucocorticoids. In addition to the existence of mechanisms regulating intracellular hormone availability, we searched for human MR splice variants involved in tissue-specific corticosteroid function. We have identified a new human MR isoform, hMRDelta5,6, resulting from an alternative splicing event skipping exons 5 and 6 of the human MR gene. hMRDelta5,6 mRNAs are expressed in several human tissues at different levels compared with wild-type human MR, as shown by real time PCR. Introduction of a premature stop codon results in a 75-kDa protein lacking the entire hinge region and ligand binding domain. Interestingly, hMRDelta5,6 is still capable of binding to DNA and acts as a ligand-independent transactivator, with maximal transcriptional induction corresponding to approximately 30-40% of aldosterone-activated wild-type human MR. Coexpression of hMRDelta5,6 with human MR or human GR increases their transactivation potential at high doses of hormone. Finally, hMRDelta5,6 is able to recruit the coactivators, steroid receptor coactivator 1, receptor interacting protein 140, and transcription intermediary factor 1alpha, which enhance its transcriptional activity. Ligand-independent transactivation and enhancement of both wild-type MR and GR activities by hMRDelta5,6 suggests that this new variant might play a role in modulating corticosteroid effects in target tissues.

Figures